Repros Therapeutics, Inc. (RPRX) Posts Q1 EPS Loss of $0.20
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $58.86 +0.67%
Financial Fact:
General and administrative: 997K
Today's EPS Names:
ALZN, ASPU, USAU, More
Financial Fact:
General and administrative: 997K
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q1 EPS of ($0.20), $0.03 worse than the analyst estimate of ($0.17).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss of $0.75/sh
- Royalty Pharma to present at upcoming investor conferences
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
